Stats + Stories: The Math Behind Prescription Drugs
WYSO is partnering with Stats and Stories, a podcast produced at Miami University.
When people think of what it takes to get a new drug approved, they likely think of the various trials a drug has to be run through, then the production and marketing of a drug once it’s ready for release. What they might not consider fully is the scope and impact of statistics in the production and manufacturing of drugs in the pharmaceutical industry. That’s the focus of this episode of Stats and Stories. Rosemary Pennington and regular panelists John Bailer, Chair of Miami’s Statistics Department and Richard Campbell former Chair of Media, Journalism and Film, are joined by Steven Ruberg. Ruberg was involved in the drug industry for almost 40 years working in all phases of development and marketing. At his last ten years at Eli Lilly he formed the advanced analytics hub for which he was the scientific leader, and eventually distinguished research Fellow. He now runs analytics thinking which he founded to promote good statistical principles and to help organizations come up with analytical strategies.
Stats and Stories is a partnership between Miami University's Departments of Statistics and Media, Journalism and Film and the American Statistical Association. You can follow us on Twitter or iTunes. If you'd like to share your thoughts on our program, send your e-mail to firstname.lastname@example.org and be sure to listen for future editions of Stats and Stories where we discuss the statistics behind the stories and the stories behind the statistics.